Evidence-based recommendations for the use of WBC-reduced cellular blood components.

Authors :: Ratko TA
Cummings JP
Oberman HA
Crookston KP
DeChristopher PJ
Eastlund DT
Godwin JE
Sacher RA
Yawn DH
Matuszewski KA
Source :: Transfusion [Transfusion] 2001 Oct; Vol. 41 (10), pp. 1310-9.
Publication Year :: 2001

Subjects :: Blood Component Transfusion adverse effects
Blood Component Transfusion methods
Blood Preservation
Cost-Benefit Analysis
Humans
Risk Assessment
United States
United States Food and Drug Administration legislation & jurisprudence
Universal Precautions
Blood Component Transfusion standards
Evidence-Based Medicine
Leukapheresis economics
Leukapheresis methods
Leukapheresis standards

Full Text Access

Tools